Journal Home
Search for

Volume 209, Issue 5, Pages 645-652 (November 2009)


View previous. 16 of 28 View next.

Gastrointestinal Malignancies: When Does Race Matter?

Timothy L. Fitzgerald, MD, FACSaCorresponding Author Information, Cathy J. Bradley, PhDb, Bassam Dahman, MSc, Emmanuel E. Zervos, MD, FACSa

Received 12 May 2009; received in revised form 7 August 2009; accepted 11 August 2009.

Background

African Americans have a poorer survival from gastrointestinal cancers. We hypothesized that socioeconomic status may explain much of this disparity.

Study Design

Four years of population-based Medicare and Medicaid administrative claims files were merged with the Michigan Tumor Registry. Data were identified for 18,260 patients with colorectal (n = 13,001), pancreatic (n = 2,427), gastric (n = 1,739), and esophageal (n = 1,093) cancer. Three outcomes were studied: the likelihood of late stage diagnosis, the likelihood of surgery after diagnosis, and survival. Bivariate analysis was used to compare stage and operation between African-American and Caucasian patients. Cox proportional hazard models were used to evaluate differences in survival. Statistical significance was defined as p < 0.05.

Results

In unadjusted analyses, relative to Caucasian patients, African-American patients with colorectal and esophageal cancer were more likely to present with metastatic disease, were less likely to have surgery, and were less likely to survive during the study period (p < 0.05). In a multivariate analysis, African-American patients had a higher likelihood of death from colorectal cancer than Caucasian patients. This difference, however, did not persist when late stage and surgery were taken into account (hazard ratio = 1.15, 95% CI = 1.06 to 1.24). No racial differences in survival were observed among patients with esophagus, gastric, or pancreatic cancer.

Conclusions

These data suggest that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes between African-American and Caucasian patients. But race has little influence on survival of patients with pancreatic, esophageal, or gastric cancer.

a Department of Surgery, Division of Surgical Oncology, East Carolina University, Greenville, NC

b Department of Health Administration and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA

c Department of Internal Medicine, Division of Quality Health Care, Virginia Commonwealth University, Richmond, VA

Corresponding Author InformationCorrespondence address: Timothy L Fitzgerald, MD, 600 Moye Blvd, 4S-20, Greenville, NC 27834

 Disclosure Information: Nothing to disclose.

 This research was supported by National Cancer Institute grant, R01-CA101835-01 In-Depth Examination of Disparities in Cancer Outcomes, Cathy J Bradley, Principal Investigator.

PII: S1072-7515(09)01216-2

doi:10.1016/j.jamcollsurg.2009.08.007


View previous. 16 of 28 View next.